Format

Send to

Choose Destination
Ann Intern Med. 2006 Jan 17;144(2):127-34.

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.

Author information

1
Clinical Addiction Research and Education (CARE) Unit, Boston University Medical Center, Boston, Massachusetts 02118, USA.

Erratum in

  • Ann Intern Med. 2006 Mar 21;144(6):460.

Abstract

More patients with opioid addiction are receiving opioid agonist therapy (OAT) with methadone and buprenorphine. As a result, physicians will more frequently encounter patients receiving OAT who develop acutely painful conditions, requiring effective treatment strategies. Undertreatment of acute pain is suboptimal medical treatment, and patients receiving long-term OAT are at particular risk. This paper acknowledges the complex interplay among addictive disease, OAT, and acute pain management and describes 4 common misconceptions resulting in suboptimal treatment of acute pain. Clinical recommendations for providing analgesia for patients with acute pain who are receiving OAT are presented. Although challenging, acute pain in patients receiving this type of therapy can effectively be managed.

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center